10/18/2024
8:23 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/09/2024
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/24/2024
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
6:07 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/08/2024
11:15 PM | Can-Fite BioPharma (Filer)
| Form EFFECT | |
09/06/2024
3:30 PM | Can-Fite BioPharma (Filer)
| Form 424B3 | |
09/05/2024
11:15 PM | Can-Fite BioPharma (Filer)
| Form EFFECT | |
|
08/30/2024
3:18 PM | Can-Fite BioPharma (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
08/30/2024
3:18 PM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2024
7:46 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/12/2024
5:45 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/09/2024
5:07 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/29/2024
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2024
12:15 PM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/01/2024
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2024
6:02 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2024
3:15 PM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/24/2024
6:04 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/10/2024
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2024
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2024
3:15 PM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2024
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2024
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024
6:11 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024
11:15 PM | Can-Fite BioPharma (Filer)
| Form EFFECT | |
04/05/2024
3:15 PM | Can-Fite BioPharma (Filer)
| Form POS AM | |
04/05/2024
3:15 PM | Can-Fite BioPharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/03/2024
6:07 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2024
8:30 AM | Can-Fite BioPharma (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/28/2024
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024
6:27 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2024
6:06 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
2:32 PM | ARMISTICE CAPITAL, LLC (Filed by)
Can-Fite BioPharma (Subject)
| Form SC 13G | |
01/30/2024
6:24 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/29/2024
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/07/2024
11:15 PM | Can-Fite BioPharma (Filer)
| Form EFFECT | |
12/28/2023
3:16 PM | Can-Fite BioPharma (Filer)
| Form F-3/A | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
12/20/2023
6:09 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2023
6:07 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023
3:15 PM | Can-Fite BioPharma (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
12/04/2023
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/30/2023
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2023
3:15 PM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2023
3:20 PM | Can-Fite BioPharma (Filer)
| Form 424B3 | |
11/21/2023
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
